Kay Hunsberger

Kay Hunsberger is an Executive Director of the Bioprocess Clinical Manufacturing and Technology (BCMT) department at Merck & Co. Inc. She is responsible for the manufacture of clinical vaccine and therapeutic products and maintenance of the Merck West Point pilot plant facility. Ms. Hunsberger’s experience spans over 30 years in the development, technical transfer and commercial manufacture of live and recombinant vaccine and biopharmaceutical products. The BCNT organization is composed of several groups including Operations, Facility Engineering, Process Automation, Capital and Equipment engineering and Compliance Operations. BCMT’s primary role is the manufacture of clinical drug substance manufacture for Merck. She received her B.S. in Biology/Biochemistry and a B.A. in Marine Science from East Stroudsburg University. She can be contacted at 215-652-1873 or email kay.hunsberger@merck.com [kay.hunsberger@merck.com].